Clearbridge Health (SGX:1H3) has issued and allotted 1.24 billion new shares under its rights issue, increasing its total share count to 1.86 billion, according to a Wednesday filing on the Singapore Exchange.
The new shares will commence trading on the SGX Catalist board from Dec. 12 and rank equally with existing shares, except for prior distributions.
Odd lots can be traded on the SGX Unit Share Market, though liquidity may be limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.